News

July 16, 2010 – Biosense Webster Inc.

Home July 15, 2010
Home
News

July 15, 2010 -- W. L. Gore and Associates recently announced that it has received the European CE mark approval for the 25 cm Gore Viabahn Endoprosthesis with Propaten Bioactive Surface. The Gore device is the longest length stent-graft available, designed to cover more of the lesion in the superficial femoral artery (SFA) potentially reducing the need for multiple devices.

Home July 15, 2010
Home
News

July 15, 2010 – The first patient has enrolled in the Retrieve 2 U.S. trial, which will evaluate the safety and efficacy of Crux Biomedical's new Vena Cava Filter (VCF). The Crux VCF is a retrievable, implantable filter that is designed to trap blood clots that can lead to a potentially fatal pulmonary embolism (PE).

Home July 15, 2010
Home
News

July 14, 2010 – The Cedars-Sinai Heart Institute has been awarded a $1.66 million, four-year grant from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) to develop a measurement system that could help doctors predict which patients could be struck by sudden cardiac arrest, a heart rhythm disturbance that causes instant death in more than 95 percent of cases

Home July 14, 2010
Home
News

July 14, 2010 – Medtronic Inc. recently announced it has received CE (Conformité Européenne) Mark for the Ensura MRI SureScan pacing system. Ensura MRI is the company’s new option in a portfolio of devices from Medtronic that have been designed, tested and approved for use with MRI machines.

Home July 14, 2010
Home
News

July 14, 2010 – A Belgian biotechnology company recently announced positive safety data and preliminary efficacy results from a clinical trial of its new stem cell therapy for heart failure.

Home July 13, 2010
Home
News

July 13, 2010 – A new analysis from the American College of Cardiology Foundation’s National Cardiovascular Data Registry (NCDR) shows that hospitals across the country are making improvements in the care of patients who have a heart attack or undergo percutaneous coronary intervention (PCI) procedures to unblock clogged coronary arteries.

Home July 13, 2010
Home
News

July 13, 2010 – AstraZeneca recently announced that the U.S. District Court has found that the substance patent protecting Crestor is valid and enforceable. In its ruling, the court found that no inequitable conduct was committed by any Shionogi employee. The court also held the '314 patent to be non-obvious and properly reissued.

Home July 13, 2010
Home
News

July 13, 2010 – A new meta-analysis of five implantable cardioverter-defibrillator (ICD) studies shows a smaller impact of sudden cardiac death (SCD) on overall mortality in women.

Home July 13, 2010
Home
News

July 12, 2010 – AngioDynamics announced today the global expansion of its Smart Port CT family of power-injectable ports, featuring its patented Vortex port technology, to include low-profile and mini models for repeated treatments such as chemotherapy and for use with computed tomography (CT).

Home July 12, 2010
Home
Technology

July 12, 2010 – GE Healthcare Medical Diagnostics today announced the market reintroduction of Optison (Perflutren Protein-Type A Microspheres Injectable Suspension, USP), a diagnostic ultrasound contrast agent for use in select echocardiograms.

Home July 12, 2010
Home
News

July 12, 2010 – Lantheus Medical Imaging Inc. today announced that it has acquired the balance of the worldwide rights for gadofosveset trisodium, a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent that it currently markets in the United States as Ablavar.

Home July 12, 2010
Home
News

July 12, 2010 – Health Level Seven Intl. (HL7), a non-profit standards development organization, has submitted comments emphasizing the need for strong health informatics standards to the European Union’s recent public open consultation on the review of the European Standardization System.

Home July 12, 2010
Home
News

July 9, 2010 – Lantheus Medical Imaging Inc. announced this week that it has signed a new manufacturing and supply agreement with MDS Nordion to purchase molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m).

Home July 09, 2010
Home
News

July 9, 2010 – W. L. Gore and Associates announced today that they are confident in the design and anticipated results of the Gore REDUCE Clinical Study, which was designed to test the safety and effectiveness of the Gore Helex Septal Occluder for patent foramen ovale (PFO) closure in patients with history of cryptogenic stroke or imaging-confirmed transient ischemic attack (TIA).

Home July 09, 2010
Home
Subscribe Now